Presenting Our First Clinical Trial Results at the American Heart Association Scientific Sessions 2026

We are proud to share that Dr. Nour Makarem, a faculty member and cardiovascular epidemiologist at the Columbia University Mailman School of Public Health, will present “The MTM4CVH Study: A Community-Based Randomized Clinical Trial of Medically Tailored Meals as a Food Is Medicine Intervention for Addressing Cardiometabolic Multimorbidity” at the American Heart Association Scientific Sessions 2026. This presentation marks an important milestone for God’s Love We Deliver: these are the first findings from the first clinical trial in our organization’s history!

Our Director of Research and Evaluation, Kelly V. Naranjo, served as Co-Investigator for the trial, which demonstrates our commitment to community-academic partnerships and to engaging community members and community health centers through a pragmatic, sustainable solution that advances health equity. This achievement reflects the dedication and collaboration between many partners across institutions. We extend our sincere thanks to our partners, the students who contributed to this work, and our colleagues at Columbia University Mailman School of Public Health, Ryan Health Community Centers, Touro University School of Osteopathic Medicine, and Temple University.

We’re so grateful to Dr. Makarem and our partners for helping to make this study a reality, especially to our amazing team who are currently supporting the project: Ariana Lopez, MPH, Marina Garcia Santos, MPH , Erica P. Wood, PhD, MPH. In addition, we want to thank former students, who also contributed to this work as research assistants: Sumanth Bushap, Eman Ibrahim, Grace Ma, Sarahy Martinez, MPH, Tianrong (KK) Chen, Lilly Krupp, Cailyn Clemons, MPH.

Kelly Naranjo tells us the importance of grounding FIM interventions in community:

Dr. Makarem tells us about the role of MTMs in promoting cardiovascular health equity: